Literature DB >> 18274524

Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays.

Brenda Summersgill1, Jeremy Clark, Janet Shipley.   

Abstract

Screening for specific genetic aberrations by fluorescence and chromogenic in situ hybridization (fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH)) can reveal associations with tumor types or subtypes, cellular morphology and clinical behavior. FISH and CISH methodologies are based on the specific annealing (hybridization) of labeled genomic sequences (probes) to complementary nucleic acids within fixed cells to allow their detection, quantification and spatial localization. Formalin-fixed paraffin embedded (FFPE) material is the most widely available source of tumor samples. Increasingly, tissue microarrays (TMAs) consisting of multiple cores of FFPE material are being used to enable simultaneous analyses of many archival samples. Here we describe robust protocols for the FISH and CISH analyses of genetic aberrations in FFPE tissue, including TMAs. Protocols include probe preparation, hybridization and detection. Steps are described to reduce background fluorescence and strip probes for repeat FISH analyses to maximize the use of tissue resources. The basic protocol takes 2-3 d to complete.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274524     DOI: 10.1038/nprot.2007.534

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  14 in total

1.  Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.

Authors:  Jilong Yang; Da Yang; Yan Sun; Baocun Sun; Guowen Wang; Jonathan C Trent; Dejka M Araujo; Kexin Chen; Wei Zhang
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

Review 2.  Prognostic and predictive value of MET deregulation in non-small cell lung cancer.

Authors:  Giovanna Finocchiaro; Luca Toschi; Letizia Gianoncelli; Marina Baretti; Armando Santoro
Journal:  Ann Transl Med       Date:  2015-04

3.  Improved Swiss-rolling Technique for Intestinal Tissue Preparation for Immunohistochemical and Immunofluorescent Analyses.

Authors:  Agnieszka B Bialkowska; Amr M Ghaleb; Mandayam O Nandan; Vincent W Yang
Journal:  J Vis Exp       Date:  2016-07-13       Impact factor: 1.355

4.  Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.

Authors:  Lieke Egbers; Manuel Luedeke; Antje Rinckleb; Suzanne Kolb; Jonathan L Wright; Christiane Maier; Marian L Neuhouser; Janet L Stanford
Journal:  Am J Epidemiol       Date:  2015-04-07       Impact factor: 4.897

5.  Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis.

Authors:  Xueying Mao; Yongwei Yu; Lara K Boyd; Guoping Ren; Dongmei Lin; Tracy Chaplin; Sakunthala C Kudahetti; Elzbieta Stankiewicz; Liyan Xue; Luis Beltran; Manu Gupta; R Tim D Oliver; Nick R Lemoine; Daniel M Berney; Bryan D Young; Yong-Jie Lu
Journal:  Cancer Res       Date:  2010-06-01       Impact factor: 12.701

6.  Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status.

Authors:  J L Wright; L Chéry; S Holt; D W Lin; M Luedeke; A E Rinckleb; C Maier; J L Stanford
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-10-27       Impact factor: 5.554

7.  OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer.

Authors:  Jin Qian; Xuan Kong; Niantao Deng; Patrick Tan; Haoyan Chen; Jilin Wang; Zhaoli Li; Ye Hu; Weiping Zou; Jie Xu; Jing-Yuan Fang
Journal:  Gut       Date:  2014-04-09       Impact factor: 23.059

8.  Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.

Authors:  Milan S Geybels; Joshi J Alumkal; Manuel Luedeke; Antje Rinckleb; Shanshan Zhao; Irene M Shui; Marina Bibikova; Brandy Klotzle; Piet A van den Brandt; Elaine A Ostrander; Jian-Bing Fan; Ziding Feng; Christiane Maier; Janet L Stanford
Journal:  Clin Epigenetics       Date:  2015-12-12       Impact factor: 6.551

9.  Fast and non-toxic in situ hybridization without blocking of repetitive sequences.

Authors:  Steen H Matthiesen; Charles M Hansen
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

10.  A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.

Authors:  Ali Amin Al Olama; Zsofia Kote-Jarai; Sonja I Berndt; David V Conti; Fredrick Schumacher; Ying Han; Sara Benlloch; Dennis J Hazelett; Zhaoming Wang; Ed Saunders; Daniel Leongamornlert; Sara Lindstrom; Sara Jugurnauth-Little; Tokhir Dadaev; Malgorzata Tymrakiewicz; Daniel O Stram; Kristin Rand; Peggy Wan; Alex Stram; Xin Sheng; Loreall C Pooler; Karen Park; Lucy Xia; Jonathan Tyrer; Laurence N Kolonel; Loic Le Marchand; Robert N Hoover; Mitchell J Machiela; Merideth Yeager; Laurie Burdette; Charles C Chung; Amy Hutchinson; Kai Yu; Chee Goh; Mahbubl Ahmed; Koveela Govindasami; Michelle Guy; Teuvo L J Tammela; Anssi Auvinen; Tiina Wahlfors; Johanna Schleutker; Tapio Visakorpi; Katri A Leinonen; Jianfeng Xu; Markus Aly; Jenny Donovan; Ruth C Travis; Tim J Key; Afshan Siddiq; Federico Canzian; Kay-Tee Khaw; Atsushi Takahashi; Michiaki Kubo; Paul Pharoah; Nora Pashayan; Maren Weischer; Borge G Nordestgaard; Sune F Nielsen; Peter Klarskov; Martin Andreas Røder; Peter Iversen; Stephen N Thibodeau; Shannon K McDonnell; Daniel J Schaid; Janet L Stanford; Suzanne Kolb; Sarah Holt; Beatrice Knudsen; Antonio Hurtado Coll; Susan M Gapstur; W Ryan Diver; Victoria L Stevens; Christiane Maier; Manuel Luedeke; Kathleen Herkommer; Antje E Rinckleb; Sara S Strom; Curtis Pettaway; Edward D Yeboah; Yao Tettey; Richard B Biritwum; Andrew A Adjei; Evelyn Tay; Ann Truelove; Shelley Niwa; Anand P Chokkalingam; Lisa Cannon-Albright; Cezary Cybulski; Dominika Wokołorczyk; Wojciech Kluźniak; Jong Park; Thomas Sellers; Hui-Yi Lin; William B Isaacs; Alan W Partin; Hermann Brenner; Aida Karina Dieffenbach; Christa Stegmaier; Constance Chen; Edward L Giovannucci; Jing Ma; Meir Stampfer; Kathryn L Penney; Lorelei Mucci; Esther M John; Sue A Ingles; Rick A Kittles; Adam B Murphy; Hardev Pandha; Agnieszka Michael; Andrzej M Kierzek; William Blot; Lisa B Signorello; Wei Zheng; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Barbara Nemesure; John Carpten; Cristina Leske; Suh-Yuh Wu; Anselm Hennis; Adam S Kibel; Benjamin A Rybicki; Christine Neslund-Dudas; Ann W Hsing; Lisa Chu; Phyllis J Goodman; Eric A Klein; S Lilly Zheng; Jyotsna Batra; Judith Clements; Amanda Spurdle; Manuel R Teixeira; Paula Paulo; Sofia Maia; Chavdar Slavov; Radka Kaneva; Vanio Mitev; John S Witte; Graham Casey; Elizabeth M Gillanders; Daniella Seminara; Elio Riboli; Freddie C Hamdy; Gerhard A Coetzee; Qiyuan Li; Matthew L Freedman; David J Hunter; Kenneth Muir; Henrik Gronberg; David E Neal; Melissa Southey; Graham G Giles; Gianluca Severi; Michael B Cook; Hidewaki Nakagawa; Fredrik Wiklund; Peter Kraft; Stephen J Chanock; Brian E Henderson; Douglas F Easton; Rosalind A Eeles; Christopher A Haiman
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.